Show results for
Refine by
Cell Morphology Mesenchymal Stem Cells Equipment Supplied In Spain
9 equipment items found
Manufactured by:Histocell based inDerio, SPAIN
The HC016 platform is a treatment of acute lung injury, based on mesenchymal stem cells derived from adipose tissue (ASC), improved with proprietary Histocell ...
Manufactured by:Histocell based inDerio, SPAIN
The HC016 platform is a treatment of acute spinal cord injury in the initial stage of the lesion, based on mesenchymal stem cells derived from adipose tissue (ASC), improved with Histocell's proprietary ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Morquio B, also known as Mucopolysaccharidosis type IV (MPS IV), is a progressive disease mostly impacting the skeleton, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding and subsequent dysfunction of GLB, which leads to the toxic substrate accumulation of keratan sulfate in organs and tissues. Very limited and ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Mucopolysaccharidosis type 1 (MPS 1) is a rare lysosomal storage disease that is caused by mutations in IDUA, the gene that encodes the alpha-L-iduronidase (IDUA) enzyme. These mutations cause the misfolding and dysfunction of IDUA, which leads to the toxic buildup of large sugars in the bone, cartilage, cornea, heart and central nervous system (CNS). There is currently no cure for these ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
GM1 Gangliosidosis is a hereditary, progressive disease mostly impacting neurons in the brain and spinal cord, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding and subsequent dysfunction of GLB, which leads to the toxic substrate accumulation of GM1 ganglioside in organs and tissues. Very limited and investigational ...
Manufactured by:Indiba based inSant Quirze del Vallès, SPAIN
The new AT7 incorporates the most advanced technology without compromising on the quality, safety and robustness that customers ...
Manufactured by:Indiba based inSant Quirze del Vallès, SPAIN
The CT8 device converts electrical current into a fixed stable frequency of 448 kHz, increasing ionic exchange at a cellular level which encourages tissue repair and assists in pain management. The return plate closes the electrical circuit, enabling our treatments to be delivered in a safe and effective manner for patients and clinicians alike. The integration of two operational modes, CAP and ...
Manufactured by:Indiba based inSant Quirze del Vallès, SPAIN
The INDIBA Activ 801 improves recovery and reduces pain. The body’s natural repair process will be accelerated and treatment of an injury can begin in the acute phase; reducing pain, swelling and speeding up ...
Manufactured by:Indiba based inSant Quirze del Vallès, SPAIN
The CT9 device converts electrical current into a fixed stable frequency of 448 kHz, increasing ionic exchange at a cellular level which encourages tissue repair and assists in pain management. The return plate closes the electrical circuit, enabling our treatments to be delivered in a safe and effective manner for patients and clinicians alike. The integration of two operational modes, CAP and ...